Maria Loose

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

International journal of cancer

Antibiotics (Basel, Switzerland)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Antimicrobial agents and chemotherapy

Justus Liebig Universitat Giessen

Justus Liebig Universitat Giessen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Justus Liebig Universitat Giessen

Germany

Postdoc :: Clinic for Urology, Pediatric Urology and Andrology

Justus Liebig Universitat Giessen

Germany

Postdoc :: Institute for Medical Microbiology

Education History

Justus Liebig Universitat Giessen

Germany

PHD :: Institute for Medical Microbiology

Publications

Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, Peter Thuss-Patience, Jorge Riera Knorrenschild, Eray Goekkurt, Gunnar Folprecht, Thomas Jens Ettrich, Udo Lindig, Kim Barbara Luley, Daniel Pink, Tobias Dechow, Disorn Sookthai, Sabine Junge, Maria Loose, Claudia Pauligk, Sylvie Lorenzen
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy. International journal of cancer (2024)
Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, Peter Thuss-Patience, Jorge Riera Knorrenschild, Eray Goekkurt, Gunnar Folprecht, Thomas Jens Ettrich, Udo Lindig, Kim Barbara Luley, Daniel Pink, Tobias Dechow, Disorn Sookthai, Sabine Junge, Maria Loose, Claudia Pauligk, Sylvie Lorenzen
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy. International journal of cancer 154 (12) (2024)
Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, Peter Thuss-Patience, Jorge Riera Knorrenschild, Eray Goekkurt, Gunnar Folprecht, Thomas Jens Ettrich, Udo Lindig, Kim Barbara Luley, Daniel Pink, Tobias Dechow, Disorn Sookthai, Sabine Junge, Maria Loose, Claudia Pauligk, Sylvie Lorenzen
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy. International journal of cancer 154 (12) (2024)
Sylvie Lorenzen, Thorsten Oliver Götze, Peter C Thuss-Patience, Matthias Biebl, Nils Homann, Michael Schenk, Udo Lindig, Vera Heuer, Albrecht Kretzschmar, Eray Goekkurt, Georg Martin Haag, Jorge Riera-Knorrenschild, Claus Bolling, Ralf-Dieter Hofheinz, Tianzuo Zhan, Stefan Angermeier, Thomas Jens Ettrich, Alexander Reinhard Siebenhüner, Moustafa Elshafei, Wolf Otto Bechstein, Timo Gaiser, Maria Loose, Disorn Sookthai, Christina Kopp, Claudia Pauligk, Salah-Eddin Al-Batran, null null
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Thorsten O Goetze, Ralf-Dieter Hofheinz, Timo Gaiser, Harald Schmalenberg, Dirk Strumberg, Eray Goekkurt, Stefan Angermeier, Thomas Zander, Hans G Kopp, Daniel Pink, Gabriele Siegler, Michael Schenk, Ferdinando De Vita, Gennaro Galizia, Evaristo Maiello, Wolf O Bechstein, Moustafa Elshafei, Maria Loose, Disorn Sookthai, Tanita Brulin, Claudia Pauligk, Nils Homann, Salah-Eddin Al-Batran
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma - A randomized phase II/III trial of the German AIO and Italian GOIM. International journal of cancer (2023)
Thorsten Oliver Goetze, Alexander Stein, Sylvie Lorenzen, Timorshah Habibzada, Eray Goekkurt, Peter Herhaus, Maria Loose, Disorn Sookthai, Tanita Brulin, Kristina Ihrig, Claudia Pauligk, Salah-Eddin Al-Batran
Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy. International journal of cancer (2023)
Thorsten O Goetze, Ralf-Dieter Hofheinz, Timo Gaiser, Harald Schmalenberg, Dirk Strumberg, Eray Goekkurt, Stefan Angermeier, Thomas Zander, Hans G Kopp, Daniel Pink, Gabriele Siegler, Michael Schenk, Ferdinando de Vita, Gennaro Galizia, Evaristo Maiello, Wolf O Bechstein, Moustafa Elshafei, Maria Loose, Disorn Sookthai, Tanita Brulin, Claudia Pauligk, Nils Homann, Salah-Eddin Al-Batran
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM. International journal of cancer (2023)
Ralf-Dieter Hofheinz, Kirsten Merx, Georg M Haag, Christoph Springfeld, Thomas Jens Ettrich, Kersten Borchert, Albrecht Kretzschmar, Christian Teschendorf, Gabriele Siegler, Matthias P A Ebert, Eray Goekkurt, Rolf Mahlberg, Nils Homann, Daniel Pink, Wolf Bechstein, Peter Reichardt, Hagen Flach, Timo Gaiser, Achim Battmann, Fuat S Oduncu, Maria Loose, Disorn Sookthai, Claudia Pauligk, Thorsten O Göetze, Salah-Eddin Al-Batran
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (32) (2022)
Maria Loose, David Sáez Moreno, Michele Mutti, Eva Hitzenhammer, Zehra Visram, David Dippel, Susanne Schertler, Lenka Podpera Tisakova, Johannes Wittmann, Lorenzo Corsini, Florian M E Wagenlehner
Natural Bred ε2-Phages Have an Improved Host Range and Virulence against Uropathogenic Escherichia coli over Their Ancestor Phages. Antibiotics (Basel, Switzerland) 10 (11) (2021)
Fabienne Hennessen, Marcus Miethke, Nestor Zaburannyi, Maria Loose, Tadeja Lukežič, Steffen Bernecker, Stephan Hüttel, Rolf Jansen, Judith Schmiedel, Moritz Fritzenwanker, Can Imirzalioglu, Jörg Vogel, Alexander J Westermann, Thomas Hesterkamp, Marc Stadler, Florian Wagenlehner, Hrvoje Petković, Jennifer Herrmann, Daniel Krug
Amidochelocardin Overcomes Resistance Mechanisms Exerted on Tetracyclines and Natural Chelocardin. Antibiotics (Basel, Switzerland) 9 (9) (2020)
Maria Loose, Emmelie Pilger, Florian Wagenlehner
Anti-Bacterial Effects of Essential Oils against Uropathogenic Bacteria. Antibiotics (Basel, Switzerland) 9 (6) (2020)
Maria Loose, Isabell Link, Kurt G Naber, Florian M E Wagenlehner
Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae. Antimicrobial agents and chemotherapy 64 (1) (2019)

Maria Loose.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maria Loose